TCT 2022 Highlights


81% Survival at 30 Days in a Multi-Center, Multi-Society Study of Impella®-Supported AMICS Patients in Japan

Junya Ako, MD, an interventional cardiologist and chair of the department of cardiovascular medicine at Kitasato University Hospital in Kanagawa, presented results of his new Japanese Registry for Percutaneous Ventricular Assist Devices (J-PVAD) study.

Saturday Lunch Symposium On-Demand: From Shock Spiral to Survival: Achieving Heart Recovery in Cardiogenic Shock


AMICS Outcomes from J-PVAD Study

Junya Ako, MD, presents outcomes in AMI cardiogenic shock from Japan's J-PVAD study.


Best Practices in Cardiogenic Shock

Katherine Kunkel, MD, discusses data-driven decision making and best practices in cardiogenic shock.


Cardiogenic Shock Working Group and SCAI Shock Stages

Navin Kapur, MD, provides an update from the Cardiogenic Shock Working Group and discusses the SCAI shock stages in this presentation.


Data Integrity in Real-World Evidence

Robert Yeh, MD, discusses how we analyze data, make treatment decisions and participate in developing clinical evidence.


Contemporary Practices for Impella-supported Complete Revascularization

Jonathan Hill, MD, discusses influential trials in high-risk PCI that are shaping the future of ischemic heart failure therapy.

Daily TCT Recaps


Live from TCT: Saturday, September 17, 2022

Seth Bilazarian, MD, and Chuck Simonton, MD, recap highlights from day one of TCT 2022 and interview Greg Stone, MD and Alaide Chieffo, MD, FESC.


Live from TCT: Sunday, September 18, 2022

This recap of highlights from day two of TCT 2022 includes interviews with Drs. Sanjit Jolly, Navin Kapur, Adrian Attinger-Toller and Taishi Hirai.


Live from TCT: Monday, September 19, 2022

Day three highlights from TCT 2022 include several late-breaking trials and interviews with Navin Kapur, MD, and Koichi Toda, MD, PhD.


More Than 235,000 Patients Supported with Impella Heart Pumps

Impella heart pumps allow a heart team to achieve high-risk revascularization and heart recovery in the cath lab and OR. Impella heart pumps provide the unique benefit of unloading the heart while providing coronary perfusion and end organ perfusion.